Co-Diagnostics Q2 EPS $(0.31) Misses $(0.24) Estimate, Sales $200.00K Miss $500.00K Estimate
Portfolio Pulse from Benzinga Newsdesk
Co-Diagnostics reported Q2 losses of $0.31 per share, missing the analyst consensus estimate of $0.24 by 29.17%. The company's quarterly sales were $200.00K, missing the estimate of $500.00K by 60.00%. This represents a 287.5% increase in losses and a 96.02% decrease in sales compared to the same period last year.
August 10, 2023 | 8:24 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Co-Diagnostics reported a significant miss in both earnings and sales for Q2, which could negatively impact the stock in the short term.
Co-Diagnostics reported a larger than expected loss and a significant decrease in sales for Q2. This underperformance could lead to a decrease in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 100
RELEVANCE 100